(Q35904936)

11 August 2017

1 reference

title

Does the genotype predict the phenotype? Evaluations of the hemostatic proteome (English)

1 reference

11 August 2017

1 reference

3

Undas A

1 reference

11 August 2017

Mann KG

1

1 reference

11 August 2017

Brummel-Ziedins K

series ordinal

2

1 reference

11 August 2017

Butenas S

series ordinal

4

1 reference

11 August 2017

publication date

1 October 2004

1 reference

Journal of Thrombosis and Haemostasis

11 August 2017

published in

1 reference

11 August 2017

volume

2

1 reference

11 August 2017

issue

10

1 reference

11 August 2017

page(s)

1727-1734

1 reference

The dynamics of thrombin formation

11 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Kinetic characterization of heparin-catalyzed and uncatalyzed inhibition of blood coagulation proteinases by antithrombin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

21 January 2018

Haemophilias A and B.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Prothrombin deficiency results in embryonic and neonatal lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Factor V: a combination of Dr Jekyll and Mr Hyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Factor VII deficiency and the FVII mutation database

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Combined deficiency of protease-activated receptor-4 and fibrinogen recapitulates the hemostatic defect but not the embryonic lethality of prothrombin deficiency

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

On-demand vs. prophylactic treatment for severe haemophilia in Norway and Sweden: differences in treatment characteristics and outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

What is all that thrombin for?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Blood coagulation at the site of microvascular injury: effects of low-dose aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Aspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Simvastatin depresses blood clotting by inhibiting activation of prothrombin, factor V, and factor XIII and by enhancing factor Va inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

A model for the stoichiometric regulation of blood coagulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Increased tissue factor-initiated prothrombin activation as a result of the Arg506 --> Gln mutation in factor VLEIDEN

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

21 January 2018

The Protein C Pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

Venous thrombosis: prevalence and interaction of risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2004.00958.X

10.1111/J.1538-7836.2004.00958.X

21 January 2018

Identifiers

DOI

1 reference

11 August 2017

1 reference